Skip to main content

Table 2 Risk of major adverse cardiovascular event over the follow-up according to SAF at baseline

From: Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study

  HR 95% Confidence interval p
SAF (per 1 AU) 4.13 1.30; 13.07 0.02
Sex
 Men 4.15 0.87; 19.77 0.07
BMI (per 1 kg/m2) 1.11 0.96; 1.27 0.16
MACE at baseline
 Yes 3.01 0.99; 9.08 0.05
Statins baseline
 Yes 2.55 0.77; 8.47 0.13
eGFR (mL/min)
  < 60 1.54 0.32; 7.31 0.59
Albumin excretion rate (mg/24 h)
  ≥ 30 1.92 0.54; 6.88 0.32
Hypertension
 Yes 2.70 0.61; 11.98 0.19
 Diabetes duration in 2009 (per 1 year) 1.02 0.98; 1.06 0.38
  1. Cox multivariate analysis (n = 205, 21 events)